Pseudomonas aeruginosa strains that produce metallo-beta-lactamases (MBLs) have been detected in many hospitals in Japan, and are becoming a common cause of nosocomial infections. Since early 2002, our hospital has experienced hospital-acquired infections due to multidrug-resistant, MBL-producing P. aeruginosa strains. We surmised that such strains have been induced by the overuse and long-term administration of carbapenems, together with insufficient infection-control measures in the hospital. Our Infection Control Team instituted, as of January 2003, strict guidelines for ensuring the correct use of antimicrobial agents, including restrictions on the indications and duration of administration of carbapenems. At the same time, strict standard prevention procedures and measures to prevent contact infections were begun. The antimicrobial use density (AUD) value for carbapenems decreased significantly (p<0.01) from 22.6±3.9 before implementation of the guidelines (Jan. 2002-Dec. 2002) to 9.3 1.3 (Jan. 2003-Dec. 2003) and 5.5±0.9 (Jan. 2004-Dec. 2004) after implementation. Moreover, the incidence of
P. aeruginosa isolates resistant to imipenem (IPM) decreased significantly (p<0.01) from 20.5% before implementation to 13.8% and then 5.7% after implementation, and the incidence of detection of multidrug-resistant
P. aeruginosa decreased significantly (p<0.01) from 5.1% to 1.7% and then 0.7%. Thus, decreased use of carbapenems and restriction of duration of administration successfully reduced the manifestation of IPM-and multidrug-resistant
P. aeruginosa. These results show the possibility of achieving control over nosocomial infections due to multidrug-resistant
P. aeruginosa by rigorously implementing institutional guidelines, including correct use of antimicrobials. There is an urgent need for preparation of standard guidelines detailing countermeasures for multidrug-resistant P
. aeruginosa, including correct management of the use of antimicrobials.
View full abstract